Morgan Stanley Bio N Tech Se Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Bio N Tech Se stock. As of the latest transaction made, Morgan Stanley holds 675,916 shares of BNTX stock, worth $76.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

675,916

Previous 1,147,797 41.11%

Holding current value

$76.4 Million

Previous $92.2 Million 12.96%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $37 Million - $58.8 Million	-471,881 Reduced 41.11%	675,916 $80.3 Million
Q2 2024 Oct 17, 2024	BUY	$80.36 - $102.87 $5.13 Million - $6.57 Million	63,887 Added 5.89%	1,147,797 $92.2 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $5.13 Million - $6.57 Million	63,887 Added 5.89%	1,147,797 $92.2 Million
Q1 2024 Oct 17, 2024	SELL	$88.96 - $112.35 $5.68 Million - $7.18 Million	-63,887 Reduced 5.57%	1,083,910 $100 Million
Q1 2024 Aug 16, 2024	BUY	$88.96 - $112.35 $40.5 Million - $51.2 Million	455,659 Added 72.53%	1,083,910 $100 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $40.5 Million - $51.2 Million	455,659 Added 72.53%	1,083,910 $100 Million
Q4 2023 Aug 16, 2024	SELL	$90.91 - $112.75 $47.2 Million - $58.6 Million	-519,546 Reduced 45.26%	628,251 $66.3 Million
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $4.32 Million - $5.36 Million	47,541 Added 8.19%	628,251 $66.3 Million
Q3 2023 Nov 15, 2023	BUY	$98.5 - $125.08 $1.03 Million - $1.31 Million	10,482 Added 1.84%	580,710 $63.1 Million
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $39.8 Million - $50.3 Million	-388,280 Reduced 40.51%	570,228 $61.5 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $62.5 Million - $78.3 Million	509,637 Added 113.54%	958,508 $119 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $12.8 Million - $20.1 Million	108,244 Added 31.78%	448,871 $67.4 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $8.42 Million - $12.1 Million	65,931 Added 24.0%	340,627 $45.9 Million
Q2 2022 Oct 27, 2022	SELL	$123.25 - $186.24 $2.58 Million - $3.9 Million	-20,965 Reduced 7.09%	274,696 $41 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $2.58 Million - $3.9 Million	-20,965 Reduced 7.09%	274,696 $41 Million
Q1 2022 Oct 27, 2022	BUY	$126.25 - $231.85 $2.65 Million - $4.86 Million	20,965 Added 7.63%	295,661 $50.4 Million
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $1.18 Million - $2.17 Million	9,346 Added 3.26%	295,661 $50.4 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $10.5 Million - $17.5 Million	-48,352 Reduced 14.45%	286,315 $73.8 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $68.9 Million - $150 Million	334,667 New	334,667 $91.4 Million

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account